Tom Wimbiscus to Present at Pharma & Biotech Patent Litigation North America
10.27.25
On Wednesday, Nov. 19, at 11:30 a.m. ET at the Philadelphia Marriott Downtown, Tom will participate on a panel entitled, “Section 112/Enablement: Finding a Path Out of Murky Waters.” The group will discuss how to adjust prosecution and litigation strategies, and preserve IP strength, given the Supreme Court’s ruling in Amgen v. Sanofi and heightened scrutiny under 112. This is part of a forum for U.S. life sciences IP leaders to help “define, shape, and create successful patent litigation strategies.”
Learn more and register here: http://bit.ly/3JqQCFg